{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:12:11Z","timestamp":1782972731005,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10633-020-09795-8","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T08:04:58Z","timestamp":1601021098000},"page":"257-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone"],"prefix":"10.1007","volume":"142","author":[{"given":"Laura","family":"Poujade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-5493","authenticated-orcid":false,"given":"Quentin","family":"Samaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3407-5265","authenticated-orcid":false,"given":"Isabelle","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-1977","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Du-Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"9795_CR1","first-page":"91","volume":"34","author":"AH Milam","year":"1993","unstructured":"Milam AH, Saari JC, Jacobson SG et al (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91\u2013100","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9795_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","volume":"21","author":"JL Keltner","year":"2001","unstructured":"Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173\u2013187. https:\/\/doi.org\/10.1097\/00041327-200109000-00004","journal-title":"J Neuroophthalmol"},{"key":"9795_CR3","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","volume":"31","author":"A Dhingra","year":"2011","unstructured":"Dhingra A, Fina ME, Neinstein A et al (2011) Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci 31:3962\u20133967. https:\/\/doi.org\/10.1523\/JNEUROSCI.6007-10.2011","journal-title":"J Neurosci"},{"key":"9795_CR4","doi-asserted-by":"publisher","first-page":"e19911","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S et al (2011) Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS ONE 6:e19911. https:\/\/doi.org\/10.1371\/journal.pone.0019911","journal-title":"PLoS ONE"},{"key":"9795_CR5","first-page":"477","volume":"33","author":"KR Alexander","year":"1992","unstructured":"Alexander KR, Fishman GA, Peachey NS et al (1992) \u201cOn\u201d response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33:477\u2013483","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9795_CR6","first-page":"262","volume":"41","author":"B Lei","year":"2000","unstructured":"Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262\u2013266","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9795_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1245\/s10434-019-07963-y","volume":"27","author":"A Livingstone","year":"2020","unstructured":"Livingstone A, Agarwal A, Stockler MR et al (2020) Preferences for immunotherapy in melanoma: a systematic review. Ann Surg Oncol 27:571\u2013584. https:\/\/doi.org\/10.1245\/s10434-019-07963-y","journal-title":"Ann Surg Oncol"},{"key":"9795_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG et al (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130:1\u201312. https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"key":"9795_CR9","doi-asserted-by":"publisher","first-page":"e0231750","DOI":"10.1371\/journal.pone.0231750","volume":"15","author":"J Varin","year":"2020","unstructured":"Varin J, Reynolds MM, Bouzidi N et al (2020) Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy. PLoS ONE 15:e0231750. https:\/\/doi.org\/10.1371\/journal.pone.0231750","journal-title":"PLoS ONE"},{"key":"9795_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/archderm.140.10.1258","volume":"140","author":"C Jacobzone","year":"2004","unstructured":"Jacobzone C, Cochard-Marianowski C, Kupfer I et al (2004) Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings. Arch Dermatol 140:1258\u20131261. https:\/\/doi.org\/10.1001\/archderm.140.10.1258","journal-title":"Arch Dermatol"},{"key":"9795_CR11","doi-asserted-by":"publisher","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","volume":"7","author":"R Yu","year":"2012","unstructured":"Yu R, Broady R, Huang Y et al (2012) Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS ONE 7:e51040. https:\/\/doi.org\/10.1371\/journal.pone.0051040","journal-title":"PLoS ONE"},{"key":"9795_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-009-0057-x","volume":"12","author":"SF Powell","year":"2010","unstructured":"Powell SF, Dudek AZ (2010) Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol 12:54\u201363. https:\/\/doi.org\/10.1007\/s11940-009-0057-x","journal-title":"Curr Treat Options Neurol"},{"key":"9795_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamaophthalmol.2019.0284","volume":"137","author":"E Karatsai","year":"2019","unstructured":"Karatsai E, Robson AG, Taylor SRJ (2019) Outcomes associated with sustained-release intraocular fluocinolone implants in a case of melanoma-associated retinopathy treated without systemic immunosuppression. JAMA Ophthalmol 137:564\u2013567. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0284","journal-title":"JAMA Ophthalmol"},{"key":"9795_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000353408","volume":"227","author":"A Audemard","year":"2013","unstructured":"Audemard A, de Raucourt S, Miocque S et al (2013) Melanoma-associated retinopathy treated with ipilimumab therapy. Dermatology 227:146\u2013149. https:\/\/doi.org\/10.1159\/000353408","journal-title":"Dermatology"},{"key":"9795_CR15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1001\/jamaophthalmol.2016.2944","volume":"134","author":"P Roberts","year":"2016","unstructured":"Roberts P, Fishman GA, Joshi K, Jampol LM (2016) Chorioretinal lesions in a case of melanoma-associated retinopathy treated with pembrolizumab. JAMA Ophthalmol 134:1184\u20131188. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.2944","journal-title":"JAMA Ophthalmol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-020-09795-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T01:16:36Z","timestamp":1632532596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-020-09795-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["9795"],"URL":"https:\/\/doi.org\/10.1007\/s10633-020-09795-8","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"This article does not contain any studies with animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"Informed consent was acquired from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no conflicts of interest, financial or material support to report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}